303 related articles for article (PubMed ID: 18658044)
1. A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
Izuhara Y; Sada T; Yanagisawa H; Koike H; Ohtomo S; Dan T; Ito S; Nangaku M; van Ypersele de Strihou C; Miyata T
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1767-73. PubMed ID: 18658044
[TBL] [Abstract][Full Text] [Related]
2. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage.
Takizawa S; Dan T; Uesugi T; Nagata E; Takagi S; van Ypersele de Strihou C; Miyata T
J Cereb Blood Flow Metab; 2009 Oct; 29(10):1665-72. PubMed ID: 19536069
[TBL] [Abstract][Full Text] [Related]
3. From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
Miyata T; Yamamoto M; Izuhara Y
Ann N Y Acad Sci; 2005 Jun; 1043():740-9. PubMed ID: 16037301
[TBL] [Abstract][Full Text] [Related]
4. Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model.
Ohtomo S; Ito M; Izuhara Y; Van Ypersele De Strihou C; Miyata T
Nephrology (Carlton); 2008 Dec; 13(6):517-21. PubMed ID: 18363646
[TBL] [Abstract][Full Text] [Related]
5. A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models.
Izuhara Y; Nangaku M; Takizawa S; Takahashi S; Shao J; Oishi H; Kobayashi H; van Ypersele de Strihou C; Miyata T
Nephrol Dial Transplant; 2008 Feb; 23(2):497-509. PubMed ID: 17928329
[TBL] [Abstract][Full Text] [Related]
6. Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model.
Tominaga N; Robert A; Izuhara Y; Ohtomo S; Dan T; Chihara K; Kurokawa K; Van Ypersele de Strihou C; Miyata T
Nephrology (Carlton); 2009 Sep; 14(6):581-7. PubMed ID: 19712258
[TBL] [Abstract][Full Text] [Related]
7. The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
Pugsley MK
Proc West Pharmacol Soc; 2005; 48():35-8. PubMed ID: 16416656
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
[TBL] [Abstract][Full Text] [Related]
9. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
Baumann M; Janssen BJ; Hermans JJ; Peutz-Kootstra C; Witzke O; Smits JF; Struijker Boudier HA
J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats.
Portero-Otín M; Pamplona R; Boada J; Jové M; Gonzalo H; Buleon M; Linz W; Schäfer S; Tack I; Girolami JP
Biochem Biophys Res Commun; 2008 Apr; 368(3):528-35. PubMed ID: 18243127
[TBL] [Abstract][Full Text] [Related]
11. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
Miyata T; Dan T
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S25-9. PubMed ID: 18954918
[TBL] [Abstract][Full Text] [Related]
13. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
[TBL] [Abstract][Full Text] [Related]
14. Chronic NF-κB blockade improves renal angiotensin II type 1 receptor functions and reduces blood pressure in Zucker diabetic rats.
Luo H; Wang X; Wang J; Chen C; Wang N; Xu Z; Chen S; Zeng C
Cardiovasc Diabetol; 2015 Jun; 14():76. PubMed ID: 26055622
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of advanced glycation end products: an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
Miyata T; Izuhara Y
Ann N Y Acad Sci; 2008 Apr; 1126():141-6. PubMed ID: 18448808
[TBL] [Abstract][Full Text] [Related]
17. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
[TBL] [Abstract][Full Text] [Related]
18. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Nangaku M; Miyata T; Sada T; Mizuno M; Inagi R; Ueda Y; Ishikawa N; Yuzawa H; Koike H; van Ypersele de Strihou C; Kurokawa K
J Am Soc Nephrol; 2003 May; 14(5):1212-22. PubMed ID: 12707391
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
Tawfik MK
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin II receptor antagonist olmesartan on renal hemodynamic variables and vascular structural properties in streptozotocin-induced diabetic rats.
Song HF; Chen JF; Sun NL; Li HW
Chin Med J (Engl); 2011 Feb; 124(4):562-7. PubMed ID: 21362282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
